U.S., Nov. 25 -- ClinicalTrials.gov registry received information related to the study (NCT07245992) titled 'A Study of F8IL10 Intra-articular Treatment in Rheumatoid Arthritis' on Aug. 19.
Brief Summary: The aim of this study is to evaluate the safety of F8IL10 when administered by intra-articular injection and to determine the maximum tolerated dose (MTD) in order to establish the recommended dose (RD) in patients with Reumatoid Arthritis.
Study Start Date: Dec., 2025
Study Type: INTERVENTIONAL
Condition:
Rheumatoid Arthritis (RA)
Intervention:
DRUG: F8IL10
Intra-articular treatment
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Philogen S.p.A.
Published by HT Digital Content Services with permission from Health Daily Digest....